Lavo Life Sciences

Accelerate Drug Development

Toolspedia Rating:

(4.7)

Paid

Lavo Life Sciences specializes in AI-accelerated crystal structure prediction for small molecule drugs. By integrating artificial intelligence with computational chemistry, Lavo provides innovative solutions that reduce the time and cost associated with drug development.

Their technology enables pharmaceutical companies to identify optimal crystal forms swiftly, minimizing risks and enhancing formulation stability.

The team at Lavo comprises experienced chemists and engineers dedicated to transforming the drug development landscape.

Their AI-powered platform not only predicts crystal structures accurately but also uncovers novel polymorphs that traditional methods might overlook. This approach ensures that potential issues are addressed early, streamlining the path from discovery to market.

Key Features:

AI-Driven Predictions: Utilizes advanced AI algorithms for accurate crystal structure forecasting.
Risk Reduction: Identifies optimal crystal forms to prevent late-stage development issues.
Novel Polymorph Discovery: Discovers new polymorphic forms that traditional methods may miss.
Formulation Optimization: Enhances drug stability and manufacturability through precise predictions.
Accelerated Timelines: Reduces time and resources required for crystal form identification.